Ignite Creation Date:
2025-12-24 @ 9:12 PM
Ignite Modification Date:
2026-05-21 @ 9:55 PM
Study NCT ID:
NCT05244304
Status:
COMPLETED
Last Update Posted:
2025-10-31
First Post:
2022-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease
Sponsor:
Belite Bio, Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
LBS-008-CT03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None